Tadalafil + Sildenafil

ApprovedCompleted

0 views this week 0 watching⚡ Active

Interest: 43/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Erectile Dysfunction

Conditions

Erectile Dysfunction

Trial Timeline

Jun 1, 2011 → Jul 1, 2012

NCT ID

NCT01352507

About Tadalafil + Sildenafil

Tadalafil + Sildenafil is a approved stage product being developed by Eli Lilly for Erectile Dysfunction. The current trial status is completed. This product is registered under clinical trial identifier NCT01352507. Target conditions include Erectile Dysfunction.

What happened to similar drugs?

11 of 20 similar drugs in Erectile Dysfunction were approved

Approved (11) Terminated (0) Active (9)

🔄tadalafil + placeboEli LillyPhase 3

✅Tacrolimus + PlaceboAstellas PharmaApproved

🔄tadalafil + placeboEli LillyPhase 3

🔄tadalafilEli LillyPhase 3

✅TadalafilEli LillyApproved

✅tadalafil + placeboEli LillyApproved

✅Tadalafil + Sildenafil CitrateEli LillyApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (4)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01352507	Approved	Completed	Jun 1, 2011	Jul 1, 2012	Erectile Dysfunction
NCT00547352	Approved	Completed	Jun 1, 2004	Jun 1, 2005	Impotence
NCT00547092	Approved	Completed	Oct 1, 2003	Nov 1, 2004	Impotence
NCT00547287	Phase 3	Completed	Nov 1, 2002	May 1, 2004	Impotence

Competing Products

20 competing products in Erectile Dysfunction

See all competitors

Product	Company	Stage	Hype Score
tadalafil + placebo	Eli Lilly	Phase 3	40
YHD1023 + YHD1023 + YHD1023 + Cialis + Placebo	Yuhan	Phase 2	35
Tacrolimus + Placebo	Astellas Pharma	Approved	43
Mirabegron	Astellas Pharma	Phase 1/2	32
LY2452473 + Tadalafil + LY900010	Eli Lilly	Phase 1	29
tadalafil + placebo	Eli Lilly	Phase 3	40
tadalafil	Eli Lilly	Phase 3	40
LY2452473 + tadalafil + placebo (tadalafil) + placebo (LY2452473)	Eli Lilly	Phase 2	35
Tadalafil	Eli Lilly	Approved	43
tadalafil + placebo	Eli Lilly	Approved	43
Tadalafil + Sildenafil Citrate	Eli Lilly	Approved	43
Tadalafil + Placebo	Eli Lilly	Phase 3	40
Placebo + Tadalafil	Eli Lilly	Approved	43
Tadalafil + Placebo	Eli Lilly	Approved	43
tadalafil	Eli Lilly	Approved	43
tadalafil once a day [T(OaD)] + sildenafil citrate as needed [S(PRN)] + tadalafil as needed [T(PRN)]	Eli Lilly	Phase 3	40
Tadalafil + Placebo	Eli Lilly	Approved	43
Dapoxetine	Johnson & Johnson	Phase 3	40
dapoxetine	Johnson & Johnson	Phase 3	40
Placebo + Dapoxetine + PDE5I (phosphodiesterase-5 inhibitor)	Johnson & Johnson	Phase 3	40